Miral, Fhebie Glein H.

HRN: 04-39-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2026
METRONIDAZOLE 500MG (TAB)
06/11/2026
06/17/2026
PO
500
TID
THICKLY MSAF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: